{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/305358385"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "20100316652VASCULAR ENDOTHELIAL CELL GROWTH FACTOR ANTAGONISTS - The present invention provides human vascular endothelial cell growth factor (hVEGF) antagonists, including monoclonal antibodies, hVEGF receptors, and hVEGF variants that are useful for the treatment of age-related macular degeneration, and other diseases and disorders characterized by undesirable or excessive neovascularization.201" ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "faqs.org" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/67485131"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/305358385" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/426439651"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/305358385" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/109881498"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/305358385"] } } }
